Search research articles
Contact Us
Filters
Showing results (1-10 of 98) with videos related to
Page
of 10
Sort By:
Journal of Bacteriology
|
December 1, 1996
The NAD(P)H-utilizing glutamate dehydrogenase of Bacteroides thetaiotaomicron belongs to enzyme family I, and its activity is affected by trans-acting gene(s) positioned downstream of gdhA
L Baggio, M Morrison
Best Practice & Research. Clinical Endocrinology & Metabolism
|
November 10, 2004
Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2
Laurie L Baggio, Daniel J Drucker
Molecular Metabolism
|
September 28, 2020
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
Laurie L Baggio, Daniel J Drucker
Gastroenterology
|
May 15, 2007
Biology of incretins: GLP-1 and GIP
Laurie L Baggio, Daniel J Drucker
The Journal of Clinical Investigation
|
September 10, 2014
Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight
Laurie L Baggio, Daniel J Drucker
Treatments in Endocrinology
|
March 16, 2005
Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review
Laurie L Baggio, Daniel J Drucker
Annual Review of Medicine
|
January 18, 2006
Therapeutic approaches to preserve islet mass in type 2 diabetes
Laurie L Baggio, Daniel J Drucker
Ultrasonics
|
October 12, 2014
Designing single-beam multitrapping acoustical tweezers
Glauber T Silva, André L Baggio
Endocrinology
|
October 3, 2000
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice
L Baggio, T J Kieffer, D J Drucker
Phlebologie
|
October 1, 1980
[The external saphenous vein and the Doppler effect]
R Lemaire, A Duvallet, L Baggio, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 98) with videos related to
Sort By:
Page
of 10
Journal of Bacteriology
|
December 1, 1996
The NAD(P)H-utilizing glutamate dehydrogenase of Bacteroides thetaiotaomicron belongs to enzyme family I, and its activity is affected by trans-acting gene(s) positioned downstream of gdhA
L Baggio, M Morrison
Best Practice & Research. Clinical Endocrinology & Metabolism
|
November 10, 2004
Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2
Laurie L Baggio, Daniel J Drucker
Molecular Metabolism
|
September 28, 2020
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
Laurie L Baggio, Daniel J Drucker
Gastroenterology
|
May 15, 2007
Biology of incretins: GLP-1 and GIP
Laurie L Baggio, Daniel J Drucker
The Journal of Clinical Investigation
|
September 10, 2014
Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight
Laurie L Baggio, Daniel J Drucker
Treatments in Endocrinology
|
March 16, 2005
Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review
Laurie L Baggio, Daniel J Drucker
Annual Review of Medicine
|
January 18, 2006
Therapeutic approaches to preserve islet mass in type 2 diabetes
Laurie L Baggio, Daniel J Drucker
Ultrasonics
|
October 12, 2014
Designing single-beam multitrapping acoustical tweezers
Glauber T Silva, André L Baggio
Endocrinology
|
October 3, 2000
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice
L Baggio, T J Kieffer, D J Drucker
Phlebologie
|
October 1, 1980
[The external saphenous vein and the Doppler effect]
R Lemaire, A Duvallet, L Baggio, et al.
Page
of 10